Biotechnology - Page 3

‘Miracle drug’ euphoria: Professionals warn in style use of weight reduction drugs faces primary hurdles

Two mavens see primary demanding situations going through the adoption of latest weight problems medication.Dr. Kavita Patel, a doctor and NBC Information clinical contributor, believes contemporary knowledge from Novo Nordisk on Ozempic’s

October 14, 2023

OpenAI

Scientists create lab-grown testicles

A couple of tiny synthetic testicles had been created in a lab, which scientists hope will supply answers to male infertility and reinforce our working out of testicular construction and serve as.Kind

February 20, 2024

Health

In 'primary milestone,' FDA approves first mobile remedy for forged tumors

Just about 4 many years after its first conception, the primary TIL remedy, an immunotherapy that harvests cancer-fighting immune cells from the affected person’s personal frame, won speeded up approval from the

February 17, 2024

Business

Why Novartis is going to walk away from its acquisition of MorphoSys

The announcement by Novartis to purchase MorphoSys for close to $3 billion is now null and void. Novartis has indicated that it will back out of the deal in the coming months,

February 6, 2024

Business

Eli Lilly Reports Exceeding Expectations with Strong Zepbound Launch and Increased Mounjaro Revenue

Eli Lilly’s quarterly results include sales of Zepbound, which some analysts predict could generate over a billion dollars in sales within its first year on the market, potentially becoming the top-selling drug

February 6, 2024

Business

Pfizer tops earnings forecasts as declining Covid business outperforms expectations

Pfizer CEO Albert Bourla spoke at a press conference with European Commission President Ursula von der Leyen after visiting the production of the Pfizer-BioNtech COVID-19 vaccine at the Pfizer factory in Puurs,

January 30, 2024

Business

Big pharma is at a critical juncture, with J&J, Merck, and other companies set to experience substantial revenue losses from their blockbuster drugs

Johnson & Johnson (NYSE: JNJ) is being welcomed to the New York Stock Exchange. Analysts on Wall Street believe that certain pharmaceutical companies are well-prepared to counter the losses they will face

January 28, 2024

Business

Humana stock plunges on dismal 2024 forecast, as insurers face soaring medical costs

The stock of Humana has dropped significantly due to a poor 2024 forecast. The company, which mainly offers government-backed insurance through the Medicare Advantage program, predicts adjusted earnings of around $16 per

January 25, 2024

Business

Gilead’s inventory tumbles towards largest selloff in additional than 9 years after lung most cancers remedy trial disappoints

Printed: Jan. 22, 2024 at 8:43 a.m. ET Stocks of Gilead Sciences Inc. GILD tumbled 10.9% beating in premarket buying and selling Monday, to pullback from an 11-month top, after the biotechnology

January 22, 2024

Business

US FDA approves Vertex/CRISPR gene treatment for an inherited blood dysfunction

The headquarters of US biopharmaceutical corporate Vertex Prescribed drugs in Boston, Massachusets, on November 4, 2023.Joseph Prezioso | Afp | Getty ImagesThe U.S. well being regulator has authorized Vertex Prescribed drugs and

January 17, 2024

Business

US FDA approves Vertex/CRISPR gene remedy for an inherited blood dysfunction

The headquarters of US biopharmaceutical corporate Vertex Prescription drugs in Boston, Massachusets, on November 4, 2023.Joseph Prezioso | Afp | Getty ImagesThe U.S. well being regulator has licensed Vertex Prescription drugs and

January 17, 2024

Business

Previous 1 2 3 4 5 6 Next

Biotechnology - Page 3

‘Miracle drug’ euphoria: Professionals warn in style use of weight reduction drugs faces primary hurdles

Scientists create lab-grown testicles

In 'primary milestone,' FDA approves first mobile remedy for forged tumors

Why Novartis is going to walk away from its acquisition of MorphoSys

Eli Lilly Reports Exceeding Expectations with Strong Zepbound Launch and Increased Mounjaro Revenue

Pfizer tops earnings forecasts as declining Covid business outperforms expectations

Big pharma is at a critical juncture, with J&J, Merck, and other companies set to experience substantial revenue losses from their blockbuster drugs

Gilead’s inventory tumbles towards largest selloff in additional than 9 years after lung most cancers remedy trial disappoints

US FDA approves Vertex/CRISPR gene treatment for an inherited blood dysfunction

US FDA approves Vertex/CRISPR gene remedy for an inherited blood dysfunction

Recent Posts

Categories

Suggestions

Biotechnology - Page 3

Recent Posts

Categories